CDY2 Inhibitors
CDY2 inhibitors belong to a specialized chemical class designed to target and modulate the activity of the CDY2 protein. The CDY2 protein, a member of the chromodomain Y (CDY) family, plays a crucial role in the epigenetic regulation of gene expression. Epigenetic modifications are reversible alterations to the DNA molecule or associated proteins that do not involve changes to the underlying DNA sequence. CDY2, characterized by its chromodomain, interacts with chromatin, contributing to the modulation of gene expression patterns. Chromodomains are known for their ability to recognize and bind to specific histone modifications, particularly those associated with either gene activation or repression.
CDY2 inhibitors act by interfering with the binding affinity between CDY2 and its target sites on chromatin. This interference disrupts the normal epigenetic regulation mediated by CDY2, potentially leading to altered gene expression profiles. As a consequence, these inhibitors offer a valuable tool for researchers studying the intricacies of epigenetic regulation and exploring the specific functions of the CDY2 protein within cellular processes. Understanding the molecular mechanisms affected by CDY2 inhibitors contributes to the broader comprehension of epigenetic control and may open avenues for the development of novel strategies to manipulate gene expression for various purposes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
As a histone deacetylase inhibitor, Vorinostat can alter chromatin structure and potentially affect the expression of a range of genes, including CDY2. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Another histone deacetylase inhibitor, Romidepsin, could change the chromatin structure around the CDY2 gene, impacting its expression. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is a potent histone deacetylase inhibitor that can affect gene expression and chromatin organization, which may include CDY2. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat is a class I histone deacetylase inhibitor that might modify the transcriptional regulation of genes like CDY2. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat is another histone deacetylase inhibitor that can modify the expression of various genes, potentially affecting CDY2. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Azacitidine, a DNA methyltransferase inhibitor, can lead to DNA demethylation and potentially disrupt gene expression patterns. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat is an HDAC inhibitor that could potentially alter the expression of genes by affecting chromatin structure and accessibility. | ||||||